{"nct_id":"NCT04923893","title":"A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2021-08-19","start_date_type":"ACTUAL","primary_completion_date":"2029-02-14","primary_completion_date_type":"ESTIMATED","completion_date":"2034-12-13","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}